Literature DB >> 20299783

Suppressor of cytokine signaling-1 ameliorates expression of MCP-1 in diabetic nephropathy.

Yonghong Shi1, Chunyang Du, Yanling Zhang, Yunzhuo Ren, Jun Hao, Song Zhao, Fang Yao, Huijun Duan.   

Abstract

BACKGROUND: Janus kinase (JAK)/signal transducers and activators of transcription (STAT) contribute to diabetic nephropathy. Suppressor of cytokine signaling-1 (SOCS-1) is one of the negative feedback regulators of JAK/STAT signaling. This study investigated the effect of SOCS-1 on the JAK/STAT pathway and MCP-1 expression in diabetic nephropathy.
METHODS: Streptozotocin-induced diabetic mice received pEF-FLAG-I/mSOCS-1 plasmid or pEF-FLAG-I vector for 4 weeks and were compared with age-matched nondiabetic mice. Functional and pathologic markers, expression of monocyte chemoattractant protein-1 (MCP-1) and TGF-beta1 and phosphorylation of STAT1 and STAT3 were assessed. The effect of SOCS-1 on the expression of MCP-1 in mesangial cells under high glucose conditions was also examined.
RESULTS: Urine albumin excretion and renal hypertrophy were alleviated in diabetic mice by overexpression of SOCS-1. The expression of TGF-beta1 and MCP-1 and the activation of STAT1 and STAT3 were significantly inhibited in diabetic kidney by gene delivery of SOCS-1. In cultured mesangial cells, overexpression of SOCS-1 markedly suppressed high glucose-induced MCP-1 expression.
CONCLUSIONS: This study suggests that SOCS-1 may attenuate renal damage by ameliorating MCP-1 expression and regulation of the phosphorylation of JAK/STAT in diabetic mice. 2010 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20299783     DOI: 10.1159/000286559

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  13 in total

1.  Interferon-γ biphasically regulates angiotensinogen expression via a JAK-STAT pathway and suppressor of cytokine signaling 1 (SOCS1) in renal proximal tubular cells.

Authors:  Ryousuke Satou; Kayoko Miyata; Romer A Gonzalez-Villalobos; Julie R Ingelfinger; L Gabriel Navar; Hiroyuki Kobori
Journal:  FASEB J       Date:  2012-02-01       Impact factor: 5.191

Review 2.  STAT signaling in polycystic kidney disease.

Authors:  Sebastian Strubl; Jacob A Torres; Alison K Spindt; Hannah Pellegrini; Max C Liebau; Thomas Weimbs
Journal:  Cell Signal       Date:  2020-04-20       Impact factor: 4.315

3.  Therapeutic effects of suppressors of cytokine signaling in diabetic nephropathy.

Authors:  Qingjuan Liu; Lingling Xing; Lei Wang; Fang Yao; Shuxia Liu; Jun Hao; Wei Liu; Huijun Duan
Journal:  J Histochem Cytochem       Date:  2013-11-11       Impact factor: 2.479

4.  Suppressor of Cytokine Signaling-1 Peptidomimetic Limits Progression of Diabetic Nephropathy.

Authors:  Carlota Recio; Iolanda Lazaro; Ainhoa Oguiza; Laura Lopez-Sanz; Susana Bernal; Julia Blanco; Jesus Egido; Carmen Gomez-Guerrero
Journal:  J Am Soc Nephrol       Date:  2016-09-08       Impact factor: 10.121

5.  Inhibition of high glucose-induced inflammatory response and macrophage infiltration by a novel curcumin derivative prevents renal injury in diabetic rats.

Authors:  Yong Pan; Yi Wang; Lu Cai; Yuepiao Cai; Jie Hu; Congcong Yu; Jianling Li; Zhiguo Feng; Shulin Yang; Xiaokun Li; Guang Liang
Journal:  Br J Pharmacol       Date:  2012-06       Impact factor: 8.739

Review 6.  JAK inhibition and progressive kidney disease.

Authors:  Frank C Brosius; John Cijiang He
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-01       Impact factor: 2.894

7.  Cell matrix contact modifies endothelial major histocompatibility complex class II expression in high-glucose environment.

Authors:  Markus Nickmann; Michael Saemisch; Ute Wilbert-Lampen; Thomas Nickel; Elazer R Edelman; Heiko Methe
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-09-16       Impact factor: 4.733

8.  miR-150 promotes renal fibrosis in lupus nephritis by downregulating SOCS1.

Authors:  Hua Zhou; Sarfaraz A Hasni; Paola Perez; Mayank Tandon; Shyh-Ing Jang; Changyu Zheng; Jeffery B Kopp; Howard Austin; James E Balow; Ilias Alevizos; Gabor G Illei
Journal:  J Am Soc Nephrol       Date:  2013-05-30       Impact factor: 10.121

Review 9.  JAK-STAT and the renin-angiotensin system: The role of the JAK-STAT pathway in blood pressure and intrarenal renin-angiotensin system regulation.

Authors:  Ryousuke Satou; Romer A Gonzalez-Villalobos
Journal:  JAKSTAT       Date:  2012-10-01

10.  DJC Suppresses Advanced Glycation End Products-Induced JAK-STAT Signaling and ROS in Mesangial Cells.

Authors:  Min Sun; Yan Li; Wenjie Bu; Jindong Zhao; Jianliang Zhu; Lingling Gu; Pingping Zhang; Zhaohui Fang
Journal:  Evid Based Complement Alternat Med       Date:  2017-05-29       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.